EAM Investors’s Aravive, Inc. Common Stock ARAV Stock Holding History

EAM Investors’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-68,282	Closed	-$933K	–	305
2019 Q4	$933K	Buy	+68,282	New	+$604K	0.21%	209

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EAM Investors's ARAV Position: Q1 2020 in Review

EAM Investors sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2020, closing a stake of 68,282 shares — an estimated $933K sold.

EAM Investors first reported a position in ARAV in Q4 2019 and held it in 1 quarter. The position peaked at $933K in Q4 2019. 35 funds tracked by Wall St. Rank hold ARAV as of Q1 2020.

EAM Investors reported no remaining Aravive, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
EAM Investors sold 68,282 Aravive, Inc. Common Stock shares in Q1 2020, an estimated $933K.
EAM Investors first reported a position in Aravive, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
EAM Investors's Aravive, Inc. Common Stock position peaked at $933K in Q4 2019.
35 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.